EHA 2022 | David Sallman | Magrolimab + Azacitidine for Untreated Higher-risk MDS, Phase 1b Results

Просмотров: 1 | Время: 03:12 | Голосов: +1 +1 | Скачать

Скачать клип EHA 2022 | David Sallman | Magrolimab + Azacitidine for Untreated Higher-risk MDS, Phase 1b Results